BSGCT Conference 2023
British Society for Gene and Cell Therapy (BSGCT) organises its annual conference in Stevenage Science Park on 22.-23. June 2023. The…
Gene therapy for Haemophilia B approved in Europe
HEMGENIX® (etranacogene dezaparvovec) has received a conditional marketing authorisation from the European Commission. UniQure, a company specialising in the development of…
Continue Reading Gene therapy for Haemophilia B approved in Europe
Finnish gene therapy for bladder cancer approved by FDA
Ferring Pharmaceuticals has announced that the novel gene therapy for bladder cancer developed by its sister company FinVector Oy has been…
Continue Reading Finnish gene therapy for bladder cancer approved by FDA
Registration for the ESGCT 28th Annual Congress is open
Registration and abstract submission portal for the European Society of Gene and Cell Therapy 28th Annual Congress in now open. The…
Continue Reading Registration for the ESGCT 28th Annual Congress is open
28th ESGCT Annual Congress postponed
28th European Society of Gene and Cell Therapy Annual Congress in Edinburgh will be postponed due to the COVID-19 pandemic. Next…
Annual congress 2020
Annual congress 2020 is organised by the parent organisation Europian Society of Gene and Cell Therapy in collaboration with BSGCT at…